Healthcare Services company Thyrocare Technologies announced Q3FY25 results Revenue: Rs 165.9 crore, compared to Rs 134.7 crore during Q3FY24, change 23% YoY. EBITDA: Rs 41.6 crore, compared to Rs 31.6 crore during Q3FY24, change 32% YoY. Consolidated gross margin stood at 73%, and normalized EBITDA margin was 30% PAT: Rs 18.9 crore, compared to Rs 14.6 crore during Q3FY24 30% YoY Pathology and Radiology segments grew by 24% YoY and 13% YoY respectively Result PDF